about
A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics.Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures.Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice.Continuous-monitoring blood culture screening system improves the detection of bacteremia in neutropenic patients.Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C.16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation.Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting.Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria.Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis.Microbial growth tests in anti-neoplastic injectable solutions.Extensive impact of non-antibiotic drugs on human gut bacteria.Antineoplastic agents inhibit the growth of Streptococcus mutans and Streptococcus sanguis in vitro.Unchanged antibiotic susceptibility in Escherichia coli and Pseudomonas aeruginosa after long-term in vitro exposure to antineoplastic drugs.
P2860
Q37204002-45AA114F-6C03-4F77-96B7-4F5BEC4971F9Q37478190-481DC64E-9B22-484F-9D96-9A901A6A78F7Q39625532-5770C444-A117-4745-B219-9EC4BCAD5B6FQ40163537-4EE223F7-232C-49FB-90D7-DF9AB7A2E64EQ40674620-41EAF3BE-82E0-4709-BC31-74FA54B2F6EDQ41987397-583B7B56-6EEA-4C7E-AC69-130ED081749CQ43548235-564ABC9C-4210-4CC0-83AE-3157531665CFQ44347574-B1D0F347-5D5A-445F-B2F5-5C908034E2B3Q44352101-139E95A6-AE94-46D0-BD43-A3DD68EADDFCQ44557436-F9095A68-7F84-4D3C-A3AC-E5720BA3C4ABQ46142208-FCC5885D-844F-4739-A3FC-FA0031C91857Q46929839-51DAAB77-624F-4CA6-894B-C99F767DA709Q52647893-5282CE24-20BE-4C92-BE66-4E0D3EB9EDCEQ54042422-54512F08-F93E-4BD4-BE76-866BABBB5F59Q54338434-DCD5578C-9D1C-4837-9A9A-0CA08B747492
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Antibacterial activities of antineoplastic agents.
@ast
Antibacterial activities of antineoplastic agents.
@en
type
label
Antibacterial activities of antineoplastic agents.
@ast
Antibacterial activities of antineoplastic agents.
@en
prefLabel
Antibacterial activities of antineoplastic agents.
@ast
Antibacterial activities of antineoplastic agents.
@en
P2093
P2860
P356
P1476
Antibacterial activities of antineoplastic agents.
@en
P2093
Bodet CA 3rd
Jorgensen JH
P2860
P304
P356
10.1128/AAC.28.3.437
P407
P577
1985-09-01T00:00:00Z